Abstract

Dyslipidaemias refers to any abnormality in the level of circulating plasma lipids. It is an extremely significant condition, majorly because of its contribution to atherogenesis. It is an independent and modifiable risk factor for CAD and stroke. More than half of global cases of ischemic heart disease are associated with dyslipidemia. Quality of care for dyslipidemia is suboptimal in general and variable by cardiovascular disease risk group, ethnicity and gender. In modern medicine, there are effective dyslipidemic drugs which give rapid relief, but may cause some long term side effects. So there is a need for safe alternative treatment which may be effective in reducing lipid level, for prolonged use. In Ayurveda, dyslipidemia can be considered as a condition in which Kapha, Medas and Rasa are pathologically deranged due to Ama. There is defective Medo dhatu poshana due to Dhatwagnimandhya and formation of Ama at the level of Medo dhatu. It can be considered as presumable level of stage of Samprapti or a morbid state which may cause disease, but not attained a full status of disease. Nidanas include Beejadushti, Ahara – vihara –vikara and Manasika nidanas. Lipid profile can be brought back to normal by correcting Agni and ensuring proper Dhatuparinama. Treatment modalities include Nidana parivarjana, Sodhana, Samana, Rasayana and following Pathyapathya. Drug having Kaphamedohara, Deepana, Pachana, Ruksha and Lekhana property is useful to treat this clinical condition.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.